Ducati

Quick links to important sections

Ducati

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ducati

Quick Facts: Cefuroxime Axetil

Property Description
Active Ingredient Cefuroxime Axetil (Prodrug of Cefuroxime)
Form Oral suspension and film-coated tablets
Pharmacological Class Second-generation cephalosporin antibiotic
General Purpose Treatment of bacterial infections
Origin Semisynthetic

What Type of Medicine is Ducati and What is its Composition?

Ducati is a trade name for a semisynthetic beta-lactam antibiotic containing the active ingredient Cefuroxime Axetil, which belongs to the second-generation cephalosporin class. This type of medicine is used to eliminate susceptible bacterial infections and is designated as prescription-only. The classification as a second-generation cephalosporin indicates its enhanced spectrum of activity against certain bacteria compared to earlier generations.

The core of this medicine’s identity is the Cefuroxime Axetil component, which is designed as a prodrug—an inactive chemical precursor that undergoes rapid chemical conversion (hydrolysis) within the body to release the therapeutically active agent, Cefuroxime. This structure and mechanism of activation are established features of the medication.

What is the General Purpose of Taking this Antibiotic?

The general purpose of this medicine is to help the body overcome harmful bacterial infections by directly killing the responsible organisms through a process known as bactericidal activity. It acts by fatally disrupting the bacteria’s essential outer structure, the bacterial cell wall, which ultimately stops and prevents further bacterial growth.

This targeted action confirms the drug's role as a reliable broad-spectrum antibiotic specifically for bacterial illnesses and clarifies that it is not effective against viral infections. The definitive bactericidal effect is achieved by the active Cefuroxime binding to specialized enzymes within the bacteria, halting the final construction phase of the cell wall.

Available Forms and Product Differentiation

The active substance Cefuroxime Axetil is primarily supplied for the oral route in two common forms: film-coated tablets and a liquid oral suspension. The availability of the oral liquid form is a key feature, as it facilitates administration to specific patient populations, particularly pediatric patients, who may require easier swallowing and more flexible dosing.

Both forms ensure consistent delivery of the prodrug for absorption. While the oral form is Cefuroxime Axetil, the parent compound, Cefuroxime, is also available separately in an injectable form for intravenous or intramuscular use in alternative, typically hospital, settings.

Regulatory References

  1. MedlinePlus: Cefuroxime

What side effects are possible with Ducati?

Cefuroxime Axetil's official safety profile is organized by frequency and System-Organ-Class (SOC) based on regulatory standards. Common adverse reactions (occurring in 1/100 to 1/10 users) primarily affect the Gastrointestinal System, including diarrhoea, nausea, and vomiting. Other common effects involve the Nervous System (reports of headache and dizziness) and the Skin (rashes and pruritus). Candida overgrowth is also classified as a frequent occurrence in regulatory documents. Uncommon effects may include temporary changes in blood counts like leucopenia or thrombocytopenia.

The regulatory documents emphasize the potential for Serious Adverse Reactions (SARs), although these are classified as Rare or Very Rare. These critical events include Anaphylaxis and other severe hypersensitivity reactions, as well as Severe Cutaneous Adverse Reactions (SCARS), such as Stevens-Johnson Syndrome (SJS). Clostridioides difficile-associated diarrhea (CDAD) is also a documented risk that may range from mild to life-threatening colitis.

Safety constraints are noted for specific patient contexts. The medicine is contraindicated in individuals with known hypersensitivity to any cephalosporin or a history of severe allergy to other beta-lactam antibacterial agents. Patients with markedly impaired renal function require specific consideration due to the drug's slower excretion. A contextually specific reaction, the Jarisch-Herxheimer reaction, is a common pattern observed following treatment of Early Lyme Disease. The medicine may also cause a false positive Coombs test during diagnostic screening.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Cefuroxime Axetil (Ducati) documents specific neurological manifestations and mandatory emergency response actions following acute overdose.

Documented Overdose Presentations

Overdosage is formally noted to cause signs of Central Nervous System (CNS) toxicity, including cerebral irritancy. Documented severe outcomes are convulsions, seizures, and neurological sequelae that may progress to encephalopathy and coma. A specific risk factor is cited for patients with renal impairment, where symptoms of overdose can occur if the maintenance dose is not appropriately reduced due to slower drug clearance.

Emergency Response and Management

Regulatory guidance requires individuals to seek immediate medical attention upon any suspicion of overdose. Emergency services must be contacted immediately if severe, life-threatening signs are observed, such as collapse, difficulty breathing, the onset of a seizure, or inability to be awakened. The poison control helpline is also identified as a necessary resource in these events.

Management is categorized as supportive and symptomatic, as no specific antidote is known. However, the active substance, Cefuroxime, is officially documented as being susceptible to removal via extracorporeal elimination procedures, including haemodialysis and peritoneal dialysis.

Therapeutic Uses of Ducati

What Ducati Treats: Main Uses and Benefits

The therapeutic utility of Cefuroxime Axetil (Ducati) is generally applied to help ease the overall symptom burden and is relevant in contexts involving infectious, heightened systemic burden, thereby helping to ease symptoms associated with acute episodes. This antibiotic is generally considered relevant for managing conditions that involve heightened systemic burden and significant symptomatic discomfort.


Therapeutic Domains of Symptom Relief

Ducati is commonly used across domains where additional symptomatic support is needed for infections such as acute bacterial sinusitis, tonsillitis, pharyngitis, and otitis media. The medication is also relevant for managing uncomplicated Urinary Tract Infections (UTIs), bacterial skin infections, and the targeted treatment of the rash in Early Lyme Disease. It helps address symptom clusters that may become intense or disruptive, including pain, fever, and localized swelling.


Quick Fact: Relief for Infection-Driven Discomfort

Feature Description
Main Symptom Axes Pain, fever, and acute inflammation/swelling related to bacterial presence.
Clinical Context Applied in acute, community-acquired episodes (e.g., sinusitis, uncomplicated UTIs).
Patient Benefit Supports the easing of the overall symptom burden and contributes to improved day-to-day comfort during symptomatic periods.

Regulatory References

  1. NIH DailyMed drug information

Eligibility and Restrictions for Use

Who Can and Cannot Use Ducati (Cefuroxime Axetil)?

Official regulatory documentation strictly defines the populations eligible to use Ducati, a second-generation cephalosporin antibiotic. This section outlines documented eligibility and non-eligibility rules.


Absolute Contraindications

Use is contraindicated in patients with a known severe hypersensitivity (allergic reaction) to cefuroxime axetil itself or to any other beta-lactam antibacterial agents, which includes all cephalosporin and penicillin antibiotics.


Age and Physiological Restrictions

Population Eligibility Status Restriction Details
Adults & Adolescents Eligible Adults and adolescents (ge 13 years) are cleared for use in approved indications.
Infants Not Established Safety and efficacy have not been established in infants younger than 3 months of age.
Pregnancy/Lactation Conditional Use Prescribed only if the benefit outweighs the risk due to limited data. Cefuroxime is excreted in human milk in small quantities.

Conditional Use and Comorbidity Rules

Use is conditional in patients with markedly impaired renal function, where official labeling recommends a dosage reduction. Safety and effectiveness have not been established in patients with gastrointestinal malabsorption. Caution is advised for individuals with a history of colitis. Additionally, the oral suspension form contains phenylalanine and is restricted for use in patients with Phenylketonuria (PKU).

What should I know about interactions with other medicines?

Interaction Map: Interactions with other medicines and products — official regulatory information for Ducati

Interaction Scope

Category Description
Medicinal product categories with documented interactions Oral Anticoagulants; Potent Diuretics (e.g., Furosemide); Drugs that reduce gastric acidity (e.g., Antacids, H2 blockers, PPIs); Combined Oral Contraceptives.
Specific interacting medicines (if explicitly listed) Probenecid.
Mechanistic basis of interactions (only if stated in label) Inhibition of renal tubular secretion (with Probenecid); Modification of gastric acidity (affects absorption); Influence on gut flora (affects estrogen reabsorption).
Timing-based interaction rules (if applicable) The medication must be administered with food to ensure optimal absorption and systemic exposure.
Population-specific interaction notes (if applicable) Patients with renal and/or hepatic impairment are identified as having a risk of reduced prothrombin activity when co-administered with anticoagulants or potent diuretics.
Interaction-related restrictions Co-administration with Probenecid is not recommended due to the resulting significant increase in Cefuroxime systemic exposure.

Interaction Classifications (High-Level)

Classification Description
Interaction severity classification (as defined in official documents) Not Recommended (Probenecid); Use with Caution (Anticoagulants, Diuretics); Clinically Significant (Gastric Acidity Reducers).
Regulatory basis (EMA / FDA / etc.) Information derived from government drug labels.
Interaction-context constraints (as defined in official documents) Bioavailability is contingent upon the presence of food and is reduced by acid-suppressing agents.

Resulting Interaction Structure

Official interaction statements:

  • Probenecid co-administration is not recommended because it inhibits renal tubular secretion, which increases the peak plasma concentration and AUC of Cefuroxime.
  • The medication must be taken with food to enhance its overall absorption and subsequent systemic exposure.
  • Co-administration with drugs that reduce gastric acidity (including H2 blockers, PPIs, and certain antacids) lowers the bioavailability of Cefuroxime Axetil.
  • Concurrent use with oral anticoagulants may lead to an increase in the International Normalized Ratio (INR).
  • There is a documented potential for reduced efficacy of combined oral contraceptives due to effects on intestinal flora.
  • Caution is advised when co-administered with potent diuretics due to the potential for adverse effects on renal function.

Connection to the overall interaction profile (2–4 sentences):

The official regulatory documents define this product's interaction structure primarily through two domains: pharmacokinetic modification and pharmacodynamic effects. The pharmacokinetic profile is notably sensitive to Probenecid, leading to reduced clearance, and to agents that alter gastric acidity, which affects absorption. The pharmacodynamic effects center on specific biological systems, including the potential for increased INR with anticoagulants and reduced efficacy of hormonal contraceptives.

Mechanism of Action

How Sacubitril/Valsartan Works

Dual Mechanism of Action

This co-formulated compound engages two primary mechanistic domains simultaneously. One component, Sacubitril (as its active metabolite LBQ657), functions as a selective inhibitor of the enzyme neprilysin (NEP). This inhibition reduces the enzymatic breakdown of endogenous natriuretic peptides and other vasoactive substrates, leading to increased circulating concentrations. This process promotes signal transduction for vasodilation and enhanced renal natriuresis.

The second component, Valsartan, acts as a competitive antagonist at the Angiotensin II Type 1 ( AT1) receptor. By blocking AT1 receptors, Valsartan prevents Angiotensin II from mediating signal transduction for vasoconstriction, aldosterone release, and adverse cardiac/vascular cellular proliferation. The synergy between these two actions—augmenting the natriuretic system and blocking the renin-angiotensin-aldosterone system (RAAS)—produces a balanced modulation of neurohormonal activity, resulting in a reduction in peripheral vascular resistance and extracellular fluid volume. This leads to reduced cardiac filling pressures and counteracts adverse myocardial and vascular remodeling processes.

Dosage and Administration Information

How to Use Cefuroxime Axetil (Ducati)

The usage of Cefuroxime Axetil, the active ingredient in Ducati, is governed by specific instructions concerning route, dosage, frequency, and administration conditions. The medicine is strictly for oral use only, available as film-coated tablets and a liquid oral suspension.


Administration Pattern and Dosing

The standard pattern involves a twice-daily schedule, meaning doses are typically taken every 12 hours for the full duration of therapy. Adult dosages commonly range from 250 mg to 500 mg per dose for most approved conditions, though a single 1,000 mg dose is specified for uncomplicated gonorrhea. Treatment duration is generally 7 to 10 days but may extend to 14 to 20 days for specific uses, such as early Lyme disease.


Contextual Use Instructions

Administration must follow specific rules depending on the form. The oral suspension is typically taken with food to ensure optimal absorption. The film-coated tablets are swallowed whole and should not be crushed or chewed. Importantly, the tablet and suspension formulations are not interchangeable on a milligram-for-milligram basis due to differences in absorption. For pediatric patients, dosing is weight-based, utilizing the oral suspension.


Population-Specific Adjustments

Standard guidance indicates that the dosing frequency be adjusted in patients with documented impaired renal function to account for reduced clearance of the medicine. If a dose is missed, common practice involves taking it as soon as remembered, unless the time for the next scheduled dose is near, in which case the missed dose is skipped; a double dose is not taken.

Recent Clinical Evidence

Ducati: Recent Clinical Evidence

Overview of Clinical Research

Clinical studies have explored the effect of this combination therapy across various phases, including preclinical, Phase 1, Phase 2, and Phase 3 trials. The research initially focused on assessing compound absorption and the overall patient response to the combination. Adverse events and tolerability were monitored in study populations of varying ages and health statuses.


Key Clinical Trial Findings

Phase 2 Studies

Phase 2 trials involved a limited number of participants and primarily assessed changes in pain indicators and symptom markers over a short-term period. Research protocols included monitoring inflammation markers and assessing symptom changes to help determine optimal dosing. High doses were also evaluated in patient populations with chronic conditions.

Phase 3 Trial Results

The pivotal Phase 3 trial reached its pre-specified primary outcome measure, comparing the combination therapy to a placebo control and standard monotherapy over a six-month duration. Studies examined the administration of the combination therapy to participants with a specific chronic condition, aiming to describe short- and long-term changes.

  • Quality of Life Assessment: Studies compared the combination's effect on quality of life indicators versus standard monotherapy.
  • Adverse Event Monitoring: The overall profile of adverse events was described across the study population. Serious adverse events were recorded for long-term monitoring.

Conclusion of Studies

Clinical studies have explored the administration of this combination therapy to participants reporting symptoms associated with the studied chronic condition. Evidence remains limited on long-term outcomes and effects in populations outside of those specifically studied. Further research is necessary to fully assess all potential effects.

Frequently Asked Questions (FAQ)

Common questions about Ducati (FAQ)


Q: Is Ducati a steroid or a type of antibiotic?

According to official product information, the active ingredient in Ducati, Cefuroxime Axetil, is a semisynthetic broad-spectrum cephalosporin antibiotic. This type of medicine works specifically to eliminate susceptible bacteria; it is not classified as a steroid.


Q: Can older adults safely take Ducati?

Regulatory documents indicate that no significant overall differences in safety or effectiveness were typically noted between older adult subjects and younger adults in clinical trials. A dosage adjustment based solely on age is not usually required, but other underlying health conditions may need to be considered.


Q: Do I need to get regular blood tests while I'm taking Ducati?

Official information mentions the medication can cause a false-positive Coombs test, which may affect certain blood screenings. Monitoring of Prothrombin time is sometimes recommended for patients considered at-risk, such as those with existing kidney or liver impairment or those concurrently taking blood-thinning medication.


Q: What should I do if the side effects of Ducati bother me a lot?

If you are experiencing side effects that are disruptive or concerning, patient guidance advises that you inform your healthcare provider. For serious or rare symptoms like severe diarrhea, difficulty breathing, or seizures, immediate medical attention should be sought.


Q: Why do some people need to take Ducati for a longer time than others?

The length of the prescribed treatment is determined by the type and severity of the bacterial infection. While most infections require a short course (often 7 to 10 days), official regulatory labels permit and sometimes require a longer duration, up to 20 days, for specific conditions like early Lyme disease.


Q: Has Ducati been around for a long time, or is it a newer drug?

The core compound, Cefuroxime, has been in clinical use for many years. The form found in Ducati, Cefuroxime Axetil, was approved by the U.S. FDA in December 1987, indicating its long-standing use in medicine.


Q: Where can I find reliable clinical trial information about Ducati?

Detailed information about the clinical trials, study populations, results, and safety findings is available in the FDA Prescribing Information and the European Medicines Agency's Summary of Product Characteristics (SmPC). These documents serve as the official regulatory basis for the drug's approval.


Q: Can I stop taking Ducati suddenly if I feel better?

It is important to complete the full course of the antibiotic exactly as prescribed by your doctor. Discontinuing treatment early, even if symptoms improve, may not fully eliminate the infection and can contribute to the development of drug-resistant bacteria.


Q: Does Ducati affect my ability to drive or operate machinery?

Official regulatory documents do not include specific studies on the effect of the drug on driving ability. However, because side effects may include dizziness and, in rare cases, other effects on the nervous system, caution may be necessary during activities requiring mental alertness.


Q: What is the maximum duration someone can take Ducati?

The longest duration listed for approved indications, based on regulatory labeling, is typically a 20-day course, which may be used for specific conditions like early Lyme disease. Use beyond the prescribed course length is not addressed in standard official labels.


Q: Does Ducati cause any changes in weight or appetite?

Loss of appetite (anorexia) was reported as an adverse reaction in a small percentage of patients during clinical trials. Changes in body weight are not specifically listed as a common or frequent side effect in the official product information.


Q: Can a history of mental health issues affect who can take Ducati?

While mental health history is not listed as an absolute restriction, official information notes that cephalosporin antibiotics may rarely cause effects like confusion or convulsions (seizures). It is important that a healthcare provider is aware of a patient's full medical history, including any prior central nervous system (CNS) issues.


Q: What are the typical expected outcomes after a course of Ducati?

The intended outcome of therapy, as described in official documents, is the successful treatment and resolution of the proven bacterial infection. Ducati is used to eliminate the bacteria responsible for the illness and help the body recover.


Q: Is there any research on Ducati's long-term safety?

Clinical studies primarily focus on the safety profile for short-term treatment durations, which are typically less than three weeks. Evidence on the long-term effects beyond the maximum approved duration remains limited in the regulatory documentation.


Q: Does Ducati interact with common cold and flu medicines?

A significant documented interaction exists with drugs that reduce stomach acid, such as antacids or acid blockers, which are sometimes components in multi-symptom cold and flu products. Using these simultaneously can reduce how much of the drug the body absorbs, decreasing its effectiveness.


Q: Can I take herbal supplements while on Ducati?

Regulatory patient guidance advises that you always inform your healthcare provider about all substances you are taking, including herbal supplements, vitamins, and minerals. This allows them to assess your regimen for any potential conflicts, even if an interaction is not formally documented.


Q: Why is the mechanism of action of Ducati important for my condition?

The mechanism is important because it is a bactericidal drug that works by inhibiting bacterial cell wall synthesis. This confirms that the medicine is intended only for treating bacterial infections and will not work against viruses (like the common cold) or non-bacterial causes of illness.

How should Ducati be stored and disposed of?

How to Store and Dispose of Cefuroxime Axetil (Ducati)

Cefuroxime Axetil storage requirements differ by form. Tablets must be stored at controlled room temperature (20 C to 25 C), kept tightly closed, and protected from excess heat and moisture. The oral suspension powder should be stored below 30 C.

Stability and Handling

Once the oral suspension is prepared, it must be refrigerated (2 C to 8 C) and must not be frozen. Any unused portion of the refrigerated suspension must be discarded after 10 days due to stability limitations. All forms must be stored out of the sight and reach of children.

Disposal

Unused or expired medicine should be disposed of using a drug take-back program. It is not on the list of medicines recommended for flushing down a toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Ducati found in:

A-Z Index: